Open access · CC-BY
via OpenAlex
Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia
Hyun-Jun Kim, Da‐Woon Jung, Darren R. Williams
Cells · 2023 · ▲ 13 citations
Abstract
Sarcopenia is a disease characterized by the progressive loss of skeletal muscle mass and function that occurs with aging. The progression of sarcopenia is correlated with the onset of physical disability, the inability to live independently, and increased mortality. Due to global increases in lifespan and demographic aging in developed countries, sarcopenia has become a major socioeconomic burden. Clinical therapies for sarcopenia are based on physical therapy and nutritional support, although these may suffer from low adherence and variable outcomes. There are currently no clinically approved drugs for sarcopenia. Consequently, there is a large amount of pre-clinical research focusing on discovering new candidate drugs and novel targets. In this review, recent progress in this research will be discussed, along with the challenges that may preclude successful translational research in the clinic. The types of drugs examined include mitochondria-targeting compounds, anti-diabetes agents, small molecules that target non-coding RNAs, protein therapeutics, natural products, and repositioning candidates. In light of the large number of drugs and targets being reported, it can be envisioned that clinically approved pharmaceuticals to prevent the progression or even mitigate sarcopenia may be within reach.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells12222608
- Canonical
- link ↗
- Fetched
- 2026-09-02 MST
Cite this
APA
Kim, H., Jung, D., & Williams, D.R. (2023). Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia. <em>Cells</em>. https://doi.org/10.3390/cells12222608
Vancouver
Kim H, Jung D, Williams DR. Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia. Cells. 2023. doi:10.3390/cells12222608.
BibTeX
@article{hyunjun2023AgeIsJ,
title = {Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia},
author = {Hyun-Jun Kim and Da‐Woon Jung and Darren R. Williams},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12222608},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Advanced Research 2025
Open access · CC-BY
Aging induces sarcopenia by disrupting the crosstalk between the skeletal muscle microenvironment and myofibers
International Journal of Molecular Sciences 2024
Open access · CC-BY
Zebrafish as a Human Muscle Model for Studying Age-Dependent Sarcopenia and Frailty
The Korean Journal of Internal Medicine 2016
Open access · CC-BY
Sarcopenia and sarcopenic obesity
Alzheimer s & Dementia Translational Research & Clinical Interventions 2022
Open access · OA
Alzheimer's disease drug development pipeline: 2022
DOAJ (DOAJ: Directory of Open Access Journals) 2025
Preprint
The Role of Skeletal Muscle Satellite Cells-mediated Muscle Regeneration in The Treatment of Age-related Sarcopenia
Journal of Applied Physiology 2003
Citation only